Baricitinib safety for events of special interest in populations at risk: analysis from randomised trial data across rheumatologic and dermatologic indications

TAYLOR PC., Bieber T., Alten R., Witte T., Galloway J., Deberdt W., Issa M., Haladyj E., De La Torre I., Grond S., Wollenberg A.

Type

Journal article

Journal

Advances in therapy

Publisher

Springer (part of Springer Nature)

Publication Date

25/01/2023

Permalink